Source:http://linkedlifedata.com/resource/pubmed/id/15236844
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2004-7-6
|
pubmed:abstractText |
6-aralkylether- and 6-arylenol-ether-substituted nipecotic acids were synthesized. These analogues are poor GABA uptake inhibitors. The electronegative region concept developed in the N-substituted nipecotic acid series cannot be transferred on the side chain of this series of 6-substituted analogues.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0223-5234
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
633-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2004
|
pubmed:articleTitle |
Syntheses and GABA uptake properties of 6-ether- and 6-enol ether-substituted nipecotic acids.
|
pubmed:affiliation |
Laboratoire de pharmacochimie de la communication cellulaire UMR7081 du CNRS, faculté de pharmacie, 74 route du Rhin, 67401 Illkirch, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|